When someone is trying to stop drinking, the right medication can make a real difference. But here’s the hard truth: even when people take their prescribed meds for alcohol use disorder (AUD), many still end up back in old patterns. It’s not because they’re weak or unmotivated. It’s because the interaction between these drugs and real-life triggers is far more complex than most people realize.
How AUD Medications Actually Work
There are three FDA-approved medications for AUD, each with a different job. Naltrexone blocks the brain’s opioid receptors. That means when someone drinks, they don’t get the same rewarding buzz. It doesn’t make you sick-it just takes the pleasure out of drinking. Studies show it cuts heavy drinking days by nearly half for people who stick with it.
Acamprosate works differently. It doesn’t touch cravings. Instead, it tries to steady the brain’s chemistry after someone stops drinking. Think of it like a buffer against the anxiety, restlessness, and sleep problems that often follow detox. It’s most effective for people who’ve already quit and want to stay stopped.
Disulfiram is the oldest-and the most dramatic. It makes your body react badly to alcohol. If you drink while on it, you get severe flushing, nausea, vomiting, and even dangerous drops in blood pressure. It’s designed as a deterrent. But here’s the catch: it only works if you take it every day and never touch alcohol. And that’s where it falls apart for most people.
The Relapse Trap: Why Meds Don’t Always Work
Here’s what most treatment programs don’t tell you: medications don’t fix your life. They just take the edge off the physical urge. If you’re still living in the same environment, surrounded by the same people, and dealing with the same stressors, the meds alone won’t hold you back.
Take naltrexone. A 2023 study of 956 people found that while it reduced heavy drinking days, it didn’t stop people from drinking at all. Many users reported, "It helped me cut back, but I still had a drink now and then." And when they did, the guilt and shame often led to a full relapse.
Acamprosate has a similar issue. You need to be completely sober for at least three to five days before starting it. That’s a big barrier for someone still drinking daily. If they slip during the first week, they stop taking it-and the chance of recovery drops sharply.
Disulfiram? It’s a gamble. People stop taking it because of side effects-metallic taste, drowsiness, fatigue. Others quit because they’re scared of accidentally drinking. One patient in a recovery forum wrote: "I was on it for two weeks. Then I had a glass of wine at a party. I panicked. I threw away the whole bottle. I didn’t go back." That’s not recovery. That’s fear.
Who Benefits Most-and Who Doesn’t
Not everyone responds the same way. Research shows your history matters more than you think.
If you’ve had severe withdrawal symptoms before-seizures, hallucinations, delirium tremens-gabapentin (not FDA-approved for AUD, but widely used off-label) might be your best bet. A 2020 trial found 45% of people with high withdrawal history stayed abstinent on gabapentin, compared to 28% on placebo. It’s gentle on the liver, which is huge if you’ve got alcohol-related liver damage.
But if you’ve never had serious withdrawal? Gabapentin barely helps. In the same study, only 32% of low-symptom users stayed sober on it-almost the same as placebo.
And genetics play a role too. A 2022 study found that people with a specific serotonin gene variant responded 2.3 times better to ondansetron (an anti-nausea drug being tested for AUD). That’s not a coincidence. It’s science.
Meanwhile, people with liver disease should avoid naltrexone. It’s processed by the liver. If your liver is already struggling, the drug can build up and cause more harm. Acamprosate? It’s cleared by the kidneys. If your kidney function is low, you need a lower dose-or to skip it altogether.
The Hidden Cost of Non-Adherence
Most people don’t realize how quickly they stop taking their meds.
NIAAA data shows only 34.7% of people prescribed AUD medications are still taking them after three months. Why? Cost. Even though most are generic, monthly prices range from $20 for disulfiram to $400 for naltrexone injections. For someone living paycheck to paycheck, that’s a luxury they can’t afford.
Side effects matter too. Acamprosate causes diarrhea in over 10% of users. Naltrexone can make you nauseous. Disulfiram? It’s a daily reminder of what you lost. And for many, that’s too much.
And then there’s the stigma. People don’t tell their doctors they stopped taking the pill. They say they’re "fine." Meanwhile, they’re back to drinking, and their liver is taking the hit.
What Actually Reduces Relapse Risk
The data is clear: medication alone isn’t enough. But medication with therapy? That’s powerful.
The landmark COMBINE study found that naltrexone plus counseling reduced heavy drinking by 40% more than naltrexone alone. Same with acamprosate. The meds create space. Therapy fills it.
And it’s not just talk therapy. Digital tools are stepping in. A 2023 Lancet study showed that using a smartphone app to track cravings and get real-time coping tips cut relapse risk by 33%. Combine that with naltrexone? The results were even better.
For people with liver disease, gabapentin plus regular liver checks cut cirrhosis decompensation events by over 50%. That’s not just about drinking-it’s about survival.
The Big Picture: Why So Few Get Help
There are 14.5 million Americans with AUD. Only 8.6% get any medication. That’s not a treatment gap. That’s a system failure.
Primary care doctors don’t feel trained to prescribe these drugs. Pharmacies don’t stock them. Insurance doesn’t always cover them. Patients don’t know they exist.
And when they do know, they’re told to "just quit." No meds. No support. Just willpower.
The truth? AUD is a medical condition. It’s not a moral failing. It’s not a lack of discipline. It’s a brain disease. And like diabetes or hypertension, it needs ongoing treatment.
The best outcome isn’t perfection. It’s progress. One less drink. One fewer blackout. One more day sober. Medications can help with that. But only if they’re used right-and only if the whole system shows up for the person trying to heal.
Can I drink while taking naltrexone?
Yes, you can drink while on naltrexone-but you won’t get the same high. The medication reduces the pleasurable effects of alcohol, which helps most people drink less. However, drinking at all still carries risk, especially if you’re trying to quit entirely. Naltrexone doesn’t protect you from alcohol’s damage to your liver, brain, or heart. It only reduces the reward. If you’re using it to cut back, that’s fine. If you’re using it to "safely" drink, you’re setting yourself up for relapse.
Why is acamprosate only for people who are already sober?
Acamprosate works by restoring balance in brain chemicals that get thrown off after heavy, long-term drinking. If you’re still drinking, those chemicals stay chaotic, and the drug can’t do its job. Starting acamprosate while drinking can make side effects like diarrhea and anxiety worse. Most guidelines require 3-5 days of complete abstinence before starting. This isn’t a quirk-it’s science. The drug needs a stable baseline to work.
Is disulfiram still worth considering?
Only for a very specific group: people who are highly motivated, have a strong support system, and understand the risks. Disulfiram creates a physical consequence for drinking-flushing, vomiting, low blood pressure. That can deter someone who’s been drinking daily. But if you’re likely to forget a dose, have a slip, or live alone, it’s dangerous. Many studies show high dropout rates because of side effects or fear. It’s not a first-line choice anymore, but for some, it’s the last resort that works.
Can I take gabapentin if I have liver damage from alcohol?
Yes, and it may be one of the safest options. Gabapentin is cleared by the kidneys, not the liver, so it doesn’t stress a damaged liver. Studies show people with cirrhosis who take gabapentin are 37-53% less likely to have life-threatening complications from liver disease. It also helps with anxiety and sleep-common issues after stopping alcohol. For someone with advanced liver damage, gabapentin can be a lifeline.
Why don’t more doctors prescribe these medications?
Most primary care doctors aren’t trained in addiction medicine. They learn about blood pressure and diabetes in med school-but not how to prescribe naltrexone or assess AUD severity. There’s also stigma. Many still see AUD as a behavioral issue, not a medical one. Plus, insurance reimbursement is patchy, and time is limited. Only 28% of primary care physicians feel confident prescribing AUD meds. Until training and policy change, this gap will keep people from getting help.